BFM
PFE icon

Boothbay Fund Management’s Pfizer PFE Stock Holding History

Boothbay Fund Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69M Buy
+194,734
New +$5.09M 0.06% 376
2026
Q1 		– Sell
-12,127
Closed -$302K – 2377
2025
Q4 		$302K Sell
12,127
-42,063
-78% -$1.06M ﹤0.01% 1425
2025
Q3 		$1.38M Sell
54,190
-32,822
-38% -$810K 0.02% 703
2025
Q2 		$2.11M Buy
+87,012
New +$2.03M 0.04% 490
2025
Q1 		– Sell
-50,336
Closed -$1.34M – 1692
2024
Q4 		$1.34M Buy
+50,336
New +$1.37M 0.03% 555
2024
Q3 		– Sell
-68,856
Closed -$1.93M – 1848
2024
Q2 		$1.93M Buy
+68,856
New +$1.9M 0.05% 513
2023
Q2 		– Sell
-148,262
Closed -$6.05M – 2184
2023
Q1 		$6.05M Buy
+148,262
New +$6.4M 0.12% 199
2022
Q4 		– Sell
-6,648
Closed -$319K – 2351
2022
Q3 		$291K Sell
6,648
-4,697
-41% -$228K 0.01% 1560
2022
Q2 		$595K Buy
11,345
+458
+4% +$23.3K 0.02% 1090
2022
Q1 		$564K Sell
10,887
-1,214,516
-99% -$63M 0.01% 1229
2021
Q4 		$72.4M Buy
+1,225,403
New +$60.7M 1.7% 5
2021
Q1 		– Sell
-7,816
Closed -$288K – 1730
2020
Q4 		$288K Buy
+7,816
New +$287K 0.01% 967
2017
Q2 		– Sell
-14,096
Closed -$458K – 801
2017
Q1 		$458K Buy
14,096
+3,834
+37% +$121K 0.09% 278
2016
Q4 		$1.06M Sell
10,262
-312
-3% -$9.53K 0.24% 78
2016
Q3 		$340K Buy
10,574
+2,098
+25% +$70.2K 0.07% 340
2016
Q2 		$283K Sell
8,476
-10,995
-56% -$351K 0.11% 265
2016
Q1 		$548K Buy
+19,471
New +$556K 0.14% 194
2015
Q4 		– Sell
-10,857
Closed -$324K – 638
2015
Q3 		$324K Buy
+10,857
New +$348K 0.15% 167
2015
Q1 		– Sell
-37,575
Closed -$222K – 399
2014
Q4 		$222K Buy
+37,575
New +$1.08M 0.17% 230

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boothbay Fund Management's PFE Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Pfizer (PFE) in Q2 2026: 194,734 shares worth $4.69M. The stake represents 0.06% of the portfolio and ranks #376 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in PFE as recently as Q4 2025.

Boothbay Fund Management first reported a position in PFE in Q4 2014 and has held it in 19 quarters since. The position peaked at $72.4M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Boothbay Fund Management held 194,734 shares of Pfizer worth $4.69M as of Q2 2026.
  • Pfizer was a new Boothbay Fund Management position in Q2 2026.
  • Pfizer made up 0.06% of Boothbay Fund Management's portfolio in Q2 2026, its #376 holding.
  • Boothbay Fund Management first reported a position in Pfizer in Q4 2014 and has held it in 19 quarters since.
  • Boothbay Fund Management's Pfizer position peaked at $72.4M in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.